Titre : Transfusion de composants du sang

Transfusion de composants du sang : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une anémie nécessitant une transfusion ?

Un diagnostic d'anémie se fait par des analyses sanguines mesurant l'hémoglobine et l'hématocrite.
Anémie Hémoglobine
#2

Quels tests précèdent une transfusion sanguine ?

Des tests de compatibilité sanguine et des analyses de groupe sanguin sont effectués.
Compatibilité sanguine Groupes sanguins
#3

Comment évaluer le besoin de plaquettes ?

On évalue le nombre de plaquettes par une numération plaquettaire dans le sang.
Plaquettes Numération plaquettaire
#4

Quels signes indiquent une transfusion de plasma ?

Des signes de coagulopathie ou d'hypoprotéinémie peuvent nécessiter une transfusion de plasma.
Coagulopathie Hypoprotéinémie
#5

Quand suspecter une hémorragie massive ?

Une hémorragie massive est suspectée en cas de perte sanguine rapide et significative.
Hémorragie Perte sanguine

Symptômes 5

#1

Quels symptômes nécessitent une transfusion ?

Fatigue extrême, pâleur, essoufflement et tachycardie peuvent indiquer un besoin de transfusion.
Fatigue Tachycardie
#2

Comment reconnaître une réaction transfusionnelle ?

Des symptômes comme fièvre, frissons, éruption cutanée ou douleur lombaire peuvent survenir.
Réaction transfusionnelle Fièvre
#3

Quels signes d'hypoxie sont préoccupants ?

Cyanose, confusion et détresse respiratoire sont des signes d'hypoxie nécessitant une transfusion.
Hypoxie Détresse respiratoire
#4

Quels symptômes indiquent une thrombopénie ?

Des saignements faciles, des ecchymoses et des pétéchies peuvent indiquer une thrombopénie.
Thrombopénie Saignements
#5

Quels symptômes d'hypoprotéinémie sont alarmants ?

Œdème, ascite et fatigue peuvent signaler une hypoprotéinémie nécessitant une transfusion de plasma.
Hypoprotéinémie Ascite

Prévention 5

#1

Comment prévenir les réactions transfusionnelles ?

La prévention passe par des tests de compatibilité et une identification précise du patient.
Réactions transfusionnelles Compatibilité sanguine
#2

Quelles mesures pour éviter les infections ?

Utiliser des produits sanguins testés et respecter les protocoles d'hygiène réduit le risque d'infection.
Infections Hygiène
#3

Comment minimiser le risque de surcharge circulatoire ?

Transfuser lentement et surveiller les signes de surcharge aide à prévenir ce risque.
Surcharge circulatoire Surveillance
#4

Quelles précautions pour les patients à risque ?

Les patients avec des antécédents de réactions transfusionnelles doivent être étroitement surveillés.
Antécédents médicaux Surveillance
#5

Comment éduquer les patients sur les transfusions ?

Informer les patients sur les risques et bénéfices des transfusions est essentiel pour leur consentement.
Éducation des patients Consentement éclairé

Traitements 5

#1

Comment se déroule une transfusion de globules rouges ?

La transfusion de globules rouges se fait par voie intraveineuse sous surveillance médicale.
Transfusion Globules rouges
#2

Quelles sont les indications pour transfuser des plaquettes ?

Les plaquettes sont transfusées en cas de thrombopénie sévère ou de saignement actif.
Thrombopénie Saignement
#3

Quand transfuser du plasma frais congelé ?

Le plasma frais congelé est transfusé pour traiter des troubles de la coagulation ou des brûlures.
Plasma Troubles de la coagulation
#4

Quels sont les risques d'une transfusion ?

Les risques incluent des réactions allergiques, des infections et des surcharges circulatoires.
Réactions allergiques Infections
#5

Comment surveiller une transfusion ?

La surveillance inclut le contrôle des signes vitaux et l'observation des réactions indésirables.
Surveillance Signes vitaux

Complications 5

#1

Quelles sont les complications possibles d'une transfusion ?

Les complications incluent des réactions allergiques, des infections et des troubles hématologiques.
Complications Réactions allergiques
#2

Comment gérer une réaction transfusionnelle ?

Cesser immédiatement la transfusion et administrer des antihistaminiques ou des corticostéroïdes.
Réaction transfusionnelle Antihistaminiques
#3

Quels sont les signes d'une surcharge circulatoire ?

Essoufflement, hypertension et œdème pulmonaire sont des signes de surcharge circulatoire.
Surcharge circulatoire Essoufflement
#4

Comment prévenir les infections post-transfusionnelles ?

Utiliser des produits sanguins testés et respecter les protocoles de transfusion réduit les risques.
Infections Protocoles de transfusion
#5

Quels sont les effets à long terme des transfusions ?

Les effets à long terme peuvent inclure l'accumulation de fer et des troubles immunitaires.
Effets à long terme Accumulation de fer

Facteurs de risque 5

#1

Quels facteurs augmentent le besoin de transfusion ?

Les chirurgies majeures, les traumatismes et les maladies hématologiques augmentent le besoin de transfusion.
Chirurgies Traumatismes
#2

Comment l'âge influence-t-il le risque de transfusion ?

Les personnes âgées ont un risque accru de complications liées aux transfusions en raison de comorbidités.
Âge Comorbidités
#3

Quels antécédents médicaux sont préoccupants ?

Des antécédents de réactions transfusionnelles ou de maladies auto-immunes augmentent les risques.
Antécédents médicaux Maladies auto-immunes
#4

Comment les maladies chroniques affectent-elles le besoin de transfusion ?

Les maladies chroniques comme l'insuffisance rénale peuvent nécessiter des transfusions fréquentes.
Maladies chroniques Insuffisance rénale
#5

Quels comportements augmentent le risque de complications ?

Le tabagisme et l'obésité peuvent augmenter le risque de complications lors des transfusions.
Tabagisme Obésité
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Transfusion de composants du sang : Questions médicales les plus fréquentes", "headline": "Transfusion de composants du sang : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Transfusion de composants du sang : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-22", "dateModified": "2026-04-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Transfusion de composants du sang" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Transfusion sanguine", "url": "https://questionsmedicales.fr/mesh/D001803", "about": { "@type": "MedicalCondition", "name": "Transfusion sanguine", "code": { "@type": "MedicalCode", "code": "D001803", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.095.135" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Transfusion d'érythrocytes", "alternateName": "Erythrocyte Transfusion", "url": "https://questionsmedicales.fr/mesh/D017707", "about": { "@type": "MedicalCondition", "name": "Transfusion d'érythrocytes", "code": { "@type": "MedicalCode", "code": "D017707", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.095.135.140.275" } } }, { "@type": "MedicalWebPage", "name": "Transfusion de leucocytes", "alternateName": "Leukocyte Transfusion", "url": "https://questionsmedicales.fr/mesh/D017708", "about": { "@type": "MedicalCondition", "name": "Transfusion de leucocytes", "code": { "@type": "MedicalCode", "code": "D017708", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.095.135.140.425" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Transfusion de lymphocytes", "alternateName": "Lymphocyte Transfusion", "url": "https://questionsmedicales.fr/mesh/D017710", "about": { "@type": "MedicalCondition", "name": "Transfusion de lymphocytes", "code": { "@type": "MedicalCode", "code": "D017710", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.095.135.140.425.445" } } } ] }, { "@type": "MedicalWebPage", "name": "Transfusion de plaquettes", "alternateName": "Platelet Transfusion", "url": "https://questionsmedicales.fr/mesh/D017713", "about": { "@type": "MedicalCondition", "name": "Transfusion de plaquettes", "code": { "@type": "MedicalCode", "code": "D017713", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "E02.095.135.140.650" } } } ], "about": { "@type": "MedicalCondition", "name": "Transfusion de composants du sang", "alternateName": "Blood Component Transfusion", "code": { "@type": "MedicalCode", "code": "D016913", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Olivier Garraud", "url": "https://questionsmedicales.fr/author/Olivier%20Garraud", "affiliation": { "@type": "Organization", "name": "GIMAP-EA3064, University of Lyon, Saint-Etienne, France; National Institute of Blood Transfusion (INTS), Paris, France." } }, { "@type": "Person", "name": "Laura Green", "url": "https://questionsmedicales.fr/author/Laura%20Green", "affiliation": { "@type": "Organization", "name": "Pathology, Barts Health NHS Trust, London, UK." } }, { "@type": "Person", "name": "E M Andrés-Esteban", "url": "https://questionsmedicales.fr/author/E%20M%20Andr%C3%A9s-Esteban", "affiliation": { "@type": "Organization", "name": "Universidad Rey Juan Carlos, Grupo PBM, Instituto de Investigación-IdiPAZ, Madrid, España." } }, { "@type": "Person", "name": "Agneta Wikman", "url": "https://questionsmedicales.fr/author/Agneta%20Wikman", "affiliation": { "@type": "Organization", "name": "Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department.", "datePublished": "2024-08-26", "url": "https://questionsmedicales.fr/article/39194129", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/0034-7167-2023-0293" } }, { "@type": "ScholarlyArticle", "name": "Parents' understanding and experiences of blood component transfusion in the neonatal intensive care unit: A qualitative study.", "datePublished": "2023-08-24", "url": "https://questionsmedicales.fr/article/37615240", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apa.16952" } }, { "@type": "ScholarlyArticle", "name": "Blood component-associated acute transfusion reactions in pediatric patients: experience of a tertiary care hospital.", "datePublished": "2024-07-16", "url": "https://questionsmedicales.fr/article/39473757", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.55730/1300-0144.5869" } }, { "@type": "ScholarlyArticle", "name": "Evaluation of a rail logistics transmission system for the transportation of blood components within a medical centre.", "datePublished": "2023-09-06", "url": "https://questionsmedicales.fr/article/37673798", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13527" } }, { "@type": "ScholarlyArticle", "name": "Microbiological environmental contamination in the blood supply chain: An international survey by the bacterial subgroup of the ISBT Transfusion-Transmitted Infectious Diseases Working Party.", "datePublished": "2023-06-04", "url": "https://questionsmedicales.fr/article/37272122", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/vox.13476" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Thérapeutique", "item": "https://questionsmedicales.fr/mesh/D013812" }, { "@type": "ListItem", "position": 3, "name": "Biothérapie", "item": "https://questionsmedicales.fr/mesh/D001691" }, { "@type": "ListItem", "position": 4, "name": "Transfusion sanguine", "item": "https://questionsmedicales.fr/mesh/D001803" }, { "@type": "ListItem", "position": 5, "name": "Transfusion de composants du sang", "item": "https://questionsmedicales.fr/mesh/D016913" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Transfusion de composants du sang - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Transfusion de composants du sang", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-11", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Transfusion de composants du sang", "description": "Comment diagnostiquer une anémie nécessitant une transfusion ?\nQuels tests précèdent une transfusion sanguine ?\nComment évaluer le besoin de plaquettes ?\nQuels signes indiquent une transfusion de plasma ?\nQuand suspecter une hémorragie massive ?", "url": "https://questionsmedicales.fr/mesh/D016913#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Transfusion de composants du sang", "description": "Quels symptômes nécessitent une transfusion ?\nComment reconnaître une réaction transfusionnelle ?\nQuels signes d'hypoxie sont préoccupants ?\nQuels symptômes indiquent une thrombopénie ?\nQuels symptômes d'hypoprotéinémie sont alarmants ?", "url": "https://questionsmedicales.fr/mesh/D016913#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Transfusion de composants du sang", "description": "Comment prévenir les réactions transfusionnelles ?\nQuelles mesures pour éviter les infections ?\nComment minimiser le risque de surcharge circulatoire ?\nQuelles précautions pour les patients à risque ?\nComment éduquer les patients sur les transfusions ?", "url": "https://questionsmedicales.fr/mesh/D016913#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Transfusion de composants du sang", "description": "Comment se déroule une transfusion de globules rouges ?\nQuelles sont les indications pour transfuser des plaquettes ?\nQuand transfuser du plasma frais congelé ?\nQuels sont les risques d'une transfusion ?\nComment surveiller une transfusion ?", "url": "https://questionsmedicales.fr/mesh/D016913#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Transfusion de composants du sang", "description": "Quelles sont les complications possibles d'une transfusion ?\nComment gérer une réaction transfusionnelle ?\nQuels sont les signes d'une surcharge circulatoire ?\nComment prévenir les infections post-transfusionnelles ?\nQuels sont les effets à long terme des transfusions ?", "url": "https://questionsmedicales.fr/mesh/D016913#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Transfusion de composants du sang", "description": "Quels facteurs augmentent le besoin de transfusion ?\nComment l'âge influence-t-il le risque de transfusion ?\nQuels antécédents médicaux sont préoccupants ?\nComment les maladies chroniques affectent-elles le besoin de transfusion ?\nQuels comportements augmentent le risque de complications ?", "url": "https://questionsmedicales.fr/mesh/D016913#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anémie nécessitant une transfusion ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic d'anémie se fait par des analyses sanguines mesurant l'hémoglobine et l'hématocrite." } }, { "@type": "Question", "name": "Quels tests précèdent une transfusion sanguine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de compatibilité sanguine et des analyses de groupe sanguin sont effectués." } }, { "@type": "Question", "name": "Comment évaluer le besoin de plaquettes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "On évalue le nombre de plaquettes par une numération plaquettaire dans le sang." } }, { "@type": "Question", "name": "Quels signes indiquent une transfusion de plasma ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des signes de coagulopathie ou d'hypoprotéinémie peuvent nécessiter une transfusion de plasma." } }, { "@type": "Question", "name": "Quand suspecter une hémorragie massive ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une hémorragie massive est suspectée en cas de perte sanguine rapide et significative." } }, { "@type": "Question", "name": "Quels symptômes nécessitent une transfusion ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue extrême, pâleur, essoufflement et tachycardie peuvent indiquer un besoin de transfusion." } }, { "@type": "Question", "name": "Comment reconnaître une réaction transfusionnelle ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme fièvre, frissons, éruption cutanée ou douleur lombaire peuvent survenir." } }, { "@type": "Question", "name": "Quels signes d'hypoxie sont préoccupants ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Cyanose, confusion et détresse respiratoire sont des signes d'hypoxie nécessitant une transfusion." } }, { "@type": "Question", "name": "Quels symptômes indiquent une thrombopénie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements faciles, des ecchymoses et des pétéchies peuvent indiquer une thrombopénie." } }, { "@type": "Question", "name": "Quels symptômes d'hypoprotéinémie sont alarmants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Œdème, ascite et fatigue peuvent signaler une hypoprotéinémie nécessitant une transfusion de plasma." } }, { "@type": "Question", "name": "Comment prévenir les réactions transfusionnelles ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par des tests de compatibilité et une identification précise du patient." } }, { "@type": "Question", "name": "Quelles mesures pour éviter les infections ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des produits sanguins testés et respecter les protocoles d'hygiène réduit le risque d'infection." } }, { "@type": "Question", "name": "Comment minimiser le risque de surcharge circulatoire ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Transfuser lentement et surveiller les signes de surcharge aide à prévenir ce risque." } }, { "@type": "Question", "name": "Quelles précautions pour les patients à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les patients avec des antécédents de réactions transfusionnelles doivent être étroitement surveillés." } }, { "@type": "Question", "name": "Comment éduquer les patients sur les transfusions ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Informer les patients sur les risques et bénéfices des transfusions est essentiel pour leur consentement." } }, { "@type": "Question", "name": "Comment se déroule une transfusion de globules rouges ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "La transfusion de globules rouges se fait par voie intraveineuse sous surveillance médicale." } }, { "@type": "Question", "name": "Quelles sont les indications pour transfuser des plaquettes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les plaquettes sont transfusées en cas de thrombopénie sévère ou de saignement actif." } }, { "@type": "Question", "name": "Quand transfuser du plasma frais congelé ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le plasma frais congelé est transfusé pour traiter des troubles de la coagulation ou des brûlures." } }, { "@type": "Question", "name": "Quels sont les risques d'une transfusion ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des réactions allergiques, des infections et des surcharges circulatoires." } }, { "@type": "Question", "name": "Comment surveiller une transfusion ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La surveillance inclut le contrôle des signes vitaux et l'observation des réactions indésirables." } }, { "@type": "Question", "name": "Quelles sont les complications possibles d'une transfusion ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des réactions allergiques, des infections et des troubles hématologiques." } }, { "@type": "Question", "name": "Comment gérer une réaction transfusionnelle ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Cesser immédiatement la transfusion et administrer des antihistaminiques ou des corticostéroïdes." } }, { "@type": "Question", "name": "Quels sont les signes d'une surcharge circulatoire ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Essoufflement, hypertension et œdème pulmonaire sont des signes de surcharge circulatoire." } }, { "@type": "Question", "name": "Comment prévenir les infections post-transfusionnelles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Utiliser des produits sanguins testés et respecter les protocoles de transfusion réduit les risques." } }, { "@type": "Question", "name": "Quels sont les effets à long terme des transfusions ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme peuvent inclure l'accumulation de fer et des troubles immunitaires." } }, { "@type": "Question", "name": "Quels facteurs augmentent le besoin de transfusion ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les chirurgies majeures, les traumatismes et les maladies hématologiques augmentent le besoin de transfusion." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque de transfusion ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées ont un risque accru de complications liées aux transfusions en raison de comorbidités." } }, { "@type": "Question", "name": "Quels antécédents médicaux sont préoccupants ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Des antécédents de réactions transfusionnelles ou de maladies auto-immunes augmentent les risques." } }, { "@type": "Question", "name": "Comment les maladies chroniques affectent-elles le besoin de transfusion ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies chroniques comme l'insuffisance rénale peuvent nécessiter des transfusions fréquentes." } }, { "@type": "Question", "name": "Quels comportements augmentent le risque de complications ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme et l'obésité peuvent augmenter le risque de complications lors des transfusions." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 11/04/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Olivier Garraud

3 publications dans cette catégorie

Affiliations :
  • GIMAP-EA3064, University of Lyon, Saint-Etienne, France; National Institute of Blood Transfusion (INTS), Paris, France.
Publications dans "Transfusion de composants du sang" :

Laura Green

3 publications dans cette catégorie

Affiliations :
  • Pathology, Barts Health NHS Trust, London, UK.
  • Blizard Institute, Queen Mary, University of London, UK, London, UK.
  • Blood Component Department, NHS Blood and Transplant, London, UK.

E M Andrés-Esteban

3 publications dans cette catégorie

Affiliations :
  • Universidad Rey Juan Carlos, Grupo PBM, Instituto de Investigación-IdiPAZ, Madrid, España.

Agneta Wikman

3 publications dans cette catégorie

Affiliations :
  • Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

Aryeh Shander

2 publications dans cette catégorie

Affiliations :
  • Department of Anesthesiology and Reanimation, Englewood Hospital & Medical Center, New Jersey, USA.
Publications dans "Transfusion de composants du sang" :

Elizabeth Dewey

2 publications dans cette catégorie

Publications dans "Transfusion de composants du sang" :

Martin Schreiber

2 publications dans cette catégorie

Publications dans "Transfusion de composants du sang" :

Yidan Zheng

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.

Li Xu

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.

Ziwen Cai

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.

Jingrong Tu

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.

Yuqi Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.

Yixuan Wang

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.

Si Chen

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.

Nianguo Dong

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.

Fei Li

2 publications dans cette catégorie

Affiliations :
  • Department of Cardiovascular Surgery, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
  • Key Laboratory of Organ Transplantation, Ministry of Education, NHC Key Laboratory of Organ Transplantation, Key Laboratory of Organ Transplantation, Chinese Academy of Medical Sciences, Wuhan, China.

Fabrice Cognasse

2 publications dans cette catégorie

Affiliations :
  • GIMAP-EA3064, University of Lyon, Saint-Etienne, France; French Blood Bank (EFS) Auvergne-Rhône-Alpes, Saint-Etienne, France.

Sources (10000 au total)

Influence of the leukoreduction moment of blood components on the clinical outcomes of transfused patients in the emergency department.

to investigate the influence of the leukoreduction moment (preor post-storage) of blood components on the clinical outcomes of patients transfused in the emergency department.... retrospective cohort study of patients aged 18 years or older who received preor post-storage leukoreduced red blood cell or platelet concentrate in the emergency department and remained in the instit... in a sample of 373 patients (63.27% male, mean age 54.83) and 643 transfusions (69.98% red blood cell), it was identified that the leukoreduction moment influenced the length of hospital stay (p<0.009... patients who received pre-storage leukoreduced blood components in the emergency department had a shorter length of hospital stay....

Parents' understanding and experiences of blood component transfusion in the neonatal intensive care unit: A qualitative study.

Blood component transfusion is a common intervention in the neonatal intensive care unit (NICU). Parents consent on their babies' behalf. This study aimed to explore parents' understandings and experi... A "low inference" qualitative descriptive semi-structured interview approach was utilised. Grounded theory was employed. Parents described their memories of babies' transfusions, their responses to th... A purposive sample of 17 parents whose babies required blood transfusion in the NICU participated. Parents talked about their initial fears of transfusion, later replaced by confidence in the process ... Parents in our study trust information from the healthcare professionals caring for their baby and would like more specific information about how blood transfusion will impact their baby, in a variety...

Blood component-associated acute transfusion reactions in pediatric patients: experience of a tertiary care hospital.

The transfusion of blood products is a life-saving clinical practice in patients with bleeding, hemoglobinopathy, and cancer. It was aimed herein to analyze the frequency and types of blood component-... This retrospective study was conducted at a tertiary care academic pediatric hospital.... During the study period, 30,811 transfusions were administered to 25,448 patients. There were 103 ATRs detected in 81 patients (0.33%; 3.34 reactions per 1000 transfusions, mean age 8.3 ± 5.98 years, ... Within our hospital, pediatric hematology-oncology wards and the stem cell transplantation unit had the most frequent ATR reports; therefore, when transfusions are carried out, increased attention sho...

Evaluation of a rail logistics transmission system for the transportation of blood components within a medical centre.

Rail logistics transmission systems (RLTSs) are commonly used for the transportation of blood samples, pathological specimens and other medical materials in many hospitals, as they are rapid, secure, ... The dispatch of blood components, including packed red blood cells (pRBCs), fresh frozen plasma (FFP), cryoprecipitate and platelet units, from a blood bank to critical care areas or general wards was... The turnaround time and temperature of all tested blood units via RLTS transportation were able to meet the clinical demands of blood component delivery (median time: 323 s [118-668 s]; temperature va... Hospital-wide delivery of blood components via RLTS seems to be safe, reliable and cost-effective and does not have any negative impact on blood quality. Therefore, the establishment of standard crite...

Microbiological environmental contamination in the blood supply chain: An international survey by the bacterial subgroup of the ISBT Transfusion-Transmitted Infectious Diseases Working Party.

Blood transfusion centres ensure the quality and safety of transfusable blood components. However, septic transfusion reactions involving environmental contaminants occur. An international survey issu... A Form survey (English and Spanish) with 35 questions was sent to ISBT-TTID-WP members. The survey had four sections: (1) respondent personal information, (2) cleaning/disinfection practices during bl... There were 49 responses from 20 countries. Five of 49 sites manufacture blood components in a cleanroom, and most use personal protective equipment, although the type varied between sites. Approximate... Data from this survey highlight the need for consensual guidelines for transfusion services regarding cleaning and disinfection practices. Environmental monitoring could be adopted to minimize the ris...

Association of body mass index with perioperative blood transfusion and short-term clinical outcomes in patients undergoing isolated coronary artery bypass grafting.

Few studies have considered outcomes among low body mass index (BMI) cohorts undergoing coronary artery bypass grafting (CABG). This study aims to investigate the effects of low body weight on blood t... This retrospective study enrolled consecutive cases from a single-center between January 2008 and December 2018. Low body weight/underweight was defined as a BMI < 18.5 kg/m², while normal BMI was def... A total of 7,620 patients were included in this study. After 1:1 propensity score matching, 130 pairs were formed, with 61 pairs in the on-pump group and 69 pairs in the off-pump group. Baseline chara... BMI < 18.5 kg/m² was identified as an independent risk factor for increased perioperative RBC transfusion rate in patient underwent isolated CABG with or without CPB. Only on-pump underweight patients...

Effect of post-storage filters vs. pre-storage filters for leukoreduction of blood components on clinical outcomes: a systematic review and meta-analysis.

Leukoreduction has been used to limit the risk of adverse events. The most commonly used methodology is filtration (pre- or post-storage). However, whether pre-storage filtration is better than post-s... We searched the MEDLINE (PubMed), CINAHL (EBSCO), PsycINFO (APA), Scopus (Elsevier), The Cochrane Library (J. Wiley), Web of Science Core Collection (Clarivate Analytics), Embase (Elsevier), and LILAC... The meta-analysis showed that pre-storage filtration was a protective factor for the occurrence of febrile non-hemolytic transfusion reaction in red blood cells (RR 0.49, 95% CI 0.41-0.59) and platele... The results of this review showed that the certainty of recommending the best type of filter (pre- or post-storage) for the benefit of the outcomes analyzed is still fragile; therefore, more robust ev... PROSPERO CRD42020192202....

Nurses' self-efficiency levels in safe blood and blood component transfusion: The case of Turkey.

The study aimed to determine nurses' self-efficacy levels for safe transfusion of blood and blood components.... The design of this study is descriptive and cross-sectional. Before starting the study, ethics committee approval and institution approval was obtained. The participants were informed about the purpos... The total SBT-SES scores of the nurses were high (202.7 ± 50.1), and the behavioral sub-factor self-efficacy scores were moderate (48.2 ± 19.5). When the SBT-SES scores were analyzed based on demograp... As a result, nurses' self-efficacy levels towards blood transfusion are high. However, the behavioral sub-factor self-efficacy level is not sufficient.... Based on these results, in order to increase the behavioral self-efficacy levels of nurses, our recommendations are as follows: investigating appropriate training methods, considering the sex factor w...

Placenta Accreta Spectrum Disorders: How to reduce maternal transfusion? A center experience on extraperitoneal retrograde hysterectomy.

Placenta Accreta Spectrum disorders (PASd) refer to the range of pathologic adherence of placenta associated with high maternal morbidity and mortality due to severe and sometimes life-threatening hem... We collected data from twelve patients with antenatal diagnosis of PASd treated between 2018 and 2021 with an extra-peritoneal hysterectomy using a posterior retrograde approach and we compared them t... The classical hysterectomy group presented a higher frequency of blood and plasma transfusion compared to the extraperitoneal hysterectomy group. In particular, classical hysterectomy resulted in an i... Even if future studies are required, we think that extraperitoneal hysterectomy could be a safe option in case of PASd, considering that classical hysterectomy compared to this approach increases, in ...